{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:46:57Z","timestamp":1775756817803,"version":"3.50.1"},"reference-count":110,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04539\/2020"],"award-info":[{"award-number":["UIDB\/04539\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SAICTPAC\/0010\/2015"],"award-info":[{"award-number":["SAICTPAC\/0010\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/BTM-TEC\/29311\/2017"],"award-info":[{"award-number":["PTDC\/BTM-TEC\/29311\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MEC-PSQ\/30943\/2017"],"award-info":[{"award-number":["PTDC\/MEC-PSQ\/30943\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MED-NEU\/27946\/2017"],"award-info":[{"award-number":["PTDC\/MED-NEU\/27946\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PD\/BD\/135178\/2017"],"award-info":[{"award-number":["PD\/BD\/135178\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rede Nacional de Espectrometria de Massa","award":["ROTEIRO\/0028\/2013"],"award-info":[{"award-number":["ROTEIRO\/0028\/2013"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Thyroid cancer is the most common endocrine system malignancy. However, there is still a lack of reliable and specific markers for the detection and staging of this disease. Fine needle aspiration biopsy is the current gold standard for diagnosis of thyroid cancer, but drawbacks to this technique include indeterminate results or an inability to discriminate different carcinomas, thereby requiring additional surgical procedures to obtain a final diagnosis. It is, therefore, necessary to seek more reliable markers to complement and improve current methods. \u201cOmics\u201d approaches have gained much attention in the last decade in the field of biomarker discovery for diagnostic and prognostic characterisation of various pathophysiological conditions. Metabolomics, in particular, has the potential to identify molecular markers of thyroid cancer and identify novel metabolic profiles of the disease, which can, in turn, help in the classification of pathological conditions and lead to a more personalised therapy, assisting in the diagnosis and in the prediction of cancer behaviour. This review considers the current results in thyroid cancer biomarker research with a focus on metabolomics.<\/jats:p>","DOI":"10.3390\/ijms21155272","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T11:16:35Z","timestamp":1595589395000},"page":"5272","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The Potential of Metabolomics in the Diagnosis of Thyroid Cancer"],"prefix":"10.3390","volume":"21","author":[{"given":"Margarida","family":"Coelho","sequence":"first","affiliation":[{"name":"CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Chemistry Department, Faculty of Sciences and Technology, University of Coimbra, 3004-535 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1001-6017","authenticated-orcid":false,"given":"Luis","family":"Raposo","sequence":"additional","affiliation":[{"name":"Thyroid Study Group, Portuguese Society of Endocrinology, Diabetes and Metabolism, 1600-892 Lisbon, Portugal"},{"name":"EPIUnit-Institute of Public Health, University of Porto, 4050-600 Porto, Portugal"}]},{"given":"Brian J.","family":"Goodfellow","sequence":"additional","affiliation":[{"name":"Department of Chemistry and CICECO, University of Aveiro, 3810-193 Aveiro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0606-4959","authenticated-orcid":false,"given":"Luigi","family":"Atzori","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Cagliari, 09042 Cagliari, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3745-3885","authenticated-orcid":false,"given":"John","family":"Jones","sequence":"additional","affiliation":[{"name":"CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2087-4042","authenticated-orcid":false,"given":"Bruno","family":"Manadas","sequence":"additional","affiliation":[{"name":"CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clon.2010.05.004","article-title":"Thyroid cancer epidemiology and prognostic variables","volume":"22","author":"Sipos","year":"2010","journal-title":"Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","article-title":"Thyroid carcinoma","volume":"361","author":"Sherma","year":"2003","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrc1836","article-title":"Pathogenetic mechanisms in thyroid follicular-cell neoplasia","volume":"6","author":"Kondo","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","first-page":"9","article-title":"Epidemiology of thyroid cancer","volume":"Volume 2","author":"Wartofsky","year":"2016","journal-title":"Thyroid Cancer: A Comprehensive Guide to Clinical Management"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1089\/105072502761016502","article-title":"Risk factors for goiter and thyroid nodules","volume":"12","author":"Knudsen","year":"2002","journal-title":"Thyroid"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Albi, E., Cataldi, S., Lazzarini, A., Codini, M., Beccari, T., Ambesi-Impiombato, F.S., and Curcio, F. (2017). Radiation and thyroid cancer. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18050911"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Ca Cancer J. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1530\/JOE-17-0266","article-title":"Key signaling pathways in thyroid cancer","volume":"235","author":"Zaballos","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/cytojournal.cytojournal_32_17","article-title":"Classification of thyroid fine-needle aspiration cytology into Bethesda categories: An institutional experience and review of the literature","volume":"15","author":"Alshaikh","year":"2018","journal-title":"Cytojournal"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000339959","article-title":"The Bethesda system for reporting thyroid cytopathology: A meta-analysis","volume":"56","author":"Bongiovanni","year":"2012","journal-title":"Acta Cytol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Gill, K.S., Tassone, P., Hamilton, J., Hjelm, N., Luginbuhl, A., Cognetti, D., Tuluc, M., Martinez-Outschoorn, U., Johnson, J.M., and Curry, J.M. (2016). Thyroid cancer metabolism: A review. J. Thyroid Disord., 5.","DOI":"10.4172\/2167-7948.C1.003"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0002-9343(92)90163-6","article-title":"Thyroid cancer in thyroid nodules: Finding a needle in the haystack","volume":"93","author":"Mazzaferri","year":"1992","journal-title":"Am. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1038\/modpathol.2008.10","article-title":"Thyroid carcinoma: Molecular pathways and therapeutic targets","volume":"21","author":"Nikiforov","year":"2008","journal-title":"Mod. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1089\/thy.2016.0547","article-title":"Molecular profiling of papillary thyroid carcinoma in Korea with a high prevalence of BRAF(V600E) mutation","volume":"27","author":"Lee","year":"2017","journal-title":"Thyroid"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/thy.2014.0241","article-title":"Prognostic value of genetic mutations in thyroid cancer: A meta-analysis","volume":"25","author":"Pak","year":"2015","journal-title":"Thyroid"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/modpathol.2008.105","article-title":"MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma","volume":"21","author":"Chen","year":"2008","journal-title":"Mod. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1245\/s10434-011-1733-0","article-title":"MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma","volume":"18","author":"Yip","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1677\/erc.1.01209","article-title":"MicroRNA deregulation in human thyroid papillary carcinomas","volume":"13","author":"Pallante","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1586\/14789450.2015.1062369","article-title":"Proteome analysis in thyroid pathology","volume":"12","author":"Pagni","year":"2015","journal-title":"Expert Rev. Proteom."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Damante, G., Scaloni, A., and Tell, G. (2009). Thyroid tumors: Novel insights from proteomic studies. Expert Rev. Proteom., 6.","DOI":"10.1586\/epr.09.51"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00109-011-0815-6","article-title":"S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging","volume":"90","author":"Nipp","year":"2012","journal-title":"J. Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1089\/thy.2009.0400","article-title":"Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma","volume":"20","author":"Sofiadis","year":"2010","journal-title":"Thyroid"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/mc.20193","article-title":"Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue","volume":"45","author":"Lewis","year":"2006","journal-title":"Mol. Carcinog."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/EJE-11-0856","article-title":"Proteomic profiling of follicular and papillary thyroid tumors","volume":"166","author":"Sofiadis","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mce.2017.11.020","article-title":"Proteome profiles of different types of thyroid cancers","volume":"472","author":"Gawin","year":"2018","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3835(03)00282-9","article-title":"14-3-3 \u03c3 possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid","volume":"200","author":"Ito","year":"2003","journal-title":"Cancer Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.anndiagpath.2016.11.003","article-title":"Heat shock proteins HSP90, HSP70 and GRP78 expression in medullary thyroid carcinoma","volume":"26","author":"Soudry","year":"2017","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1349-7006.2011.02181.x","article-title":"HIF-1alpha and HSP90: Target molecules selected from a tumorigenic papillary thyroid carcinoma cell line","volume":"103","author":"Mo","year":"2012","journal-title":"Cancer Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"43990","DOI":"10.1074\/jbc.M407503200","article-title":"Inhibition of heat shock protein 90, a novel RET\/PTC1-associated protein, increases radioiodide accumulation in thyroid cells","volume":"279","author":"Marsee","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.surg.2015.07.050","article-title":"Novel HSP90 inhibitors effectively target functions of thyroid cancer stem cell preventing migration and invasion","volume":"159","author":"White","year":"2016","journal-title":"Surgery"},{"key":"ref_31","first-page":"141","article-title":"Hsp90 as a therapeutic target in endocrinology: Current evidence","volume":"5","author":"Ward","year":"2015","journal-title":"Res. Rep. Endocr. Disord."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"41294","DOI":"10.18632\/oncotarget.17180","article-title":"Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41598-018-36415-y","article-title":"Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state","volume":"9","author":"Deidda","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biocel.2017.07.024","article-title":"Metabolomic profile in hyperthyroid patients before and after antithyroid drug treatment: Correlation with thyroid hormone and TSH concentration","volume":"93","author":"Piras","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrcardio.2011.138","article-title":"Metabolomics as a tool for cardiac research","volume":"8","author":"Griffin","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijcard.2017.04.024","article-title":"Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension","volume":"241","author":"Deidda","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/14767058.2014.955966","article-title":"Urinary metabolomics of bronchopulmonary dysplasia (BPD): Preliminary data at birth suggest it is a congenital disease","volume":"27","author":"Fanos","year":"2014","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/jpm-2018-0314","article-title":"Metabolic scharacterisation of amniotic fluids of fetuses with enlarged nuchal translucency","volume":"47","author":"Iuculano","year":"2019","journal-title":"J. Perinat. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Bingol, K. (2018). Recent advances in targeted and untargeted metabolomics by NMR and MS\/NMR methods. High Throughput, 7.","DOI":"10.3390\/ht7020009"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.1093\/nar\/gky310","article-title":"MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis","volume":"46","author":"Chong","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/mas.21562","article-title":"Challenges and emergent solutions for LC-MS\/MS based untargeted metabolomics in diseases","volume":"37","author":"Cui","year":"2018","journal-title":"Mass Spectrom. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1364\/BOE.10.004411","article-title":"Hyperspectral Raman microscopy can accurately differentiate single cells of different human thyroid nodules","volume":"10","author":"Campbell","year":"2019","journal-title":"Biomed. Opt. Express"},{"key":"ref_43","first-page":"2361","article-title":"Thyroid tissue analysis through Raman spectroscopy","volume":"134","author":"Teixeira","year":"2009","journal-title":"Analytic"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0002-9343(94)90071-X","article-title":"Proton magnetic resonance and human thyroid neoplasia I: Discrimination between benign and malignant neoplasms","volume":"96","author":"Russell","year":"1994","journal-title":"Am. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s002689900128","article-title":"Two-dimensional proton magnetic resonance spectroscopy for tissue scharacterisation of thyroid neoplasms","volume":"20","author":"Mackinnon","year":"1996","journal-title":"World J. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejrad.2004.05.003","article-title":"In vivo 1H MR spectroscopy of thyroid carcinoma","volume":"54","author":"King","year":"2005","journal-title":"Eur. J. Radiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archsurg.2010.345","article-title":"Evaluation of the role of magnetic resonance spectroscopy in the diagnosis of follicular malignancies of thyroid","volume":"146","author":"Gupta","year":"2011","journal-title":"Arch. Surg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejrad.2007.03.006","article-title":"Magnetic resonance spectroscopy as a diagnostic modality for carcinoma thyroid","volume":"64","author":"Gupta","year":"2007","journal-title":"Eur. J. Radiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/1099-1492(200011)13:7<377::AID-NBM658>3.0.CO;2-E","article-title":"Quantitation by (1)H-NMR of dolichol, cholesterol and choline-containing lipids in extracts of normal and phathological thyroid tissue","volume":"13","author":"Yoshioka","year":"2000","journal-title":"Nmr Biomed."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1099-1492(200002)13:1<8::AID-NBM602>3.0.CO;2-X","article-title":"Systemic alterations in phospholipid concentrations of blood plasma in patients with thyroid carcinoma: An in-vitro 31P high-resolution NMR study","volume":"13","author":"Raffelt","year":"2000","journal-title":"Nmr Biomed."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1159\/000333271","article-title":"Application of magnetic-resonance-spectroscopy- based metabolomics to the fine-needle aspiration diagnosis of papillary thyroid carcinoma","volume":"55","author":"Jordan","year":"2011","journal-title":"Acta Cytol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1039\/c1mb05029j","article-title":"Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter","volume":"7","author":"Yao","year":"2011","journal-title":"Mol. Biosyst."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.surg.2012.08.037","article-title":"Metabolomics approach to thyroid nodules: A high-resolution magic-angle spinning nuclear magnetic resonance-based study","volume":"152","author":"Miccoli","year":"2012","journal-title":"Surgery"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1021\/pr300105e","article-title":"Toward the reliable diagnosis of indeterminate thyroid lesions: A HRMAS NMR-based metabolomics case of study","volume":"11","author":"Torregrossa","year":"2012","journal-title":"J. Proteome Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.surg.2015.12.029","article-title":"ROC-ing along: Evaluation and interpretation of receiver operating characteristic curves","volume":"159","author":"Carter","year":"2016","journal-title":"Surgery"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"81768","DOI":"10.18632\/oncotarget.13178","article-title":"Non-invasive diagnosis of papillary thyroid microcarcinoma: A NMR-based metabolomics approach","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11306-018-1437-6","article-title":"Diagnosis of post-surgical fine-needle aspiration biopsies of thyroid lesions with indeterminate cytology using HRMAS NMR-based metabolomics","volume":"14","author":"Rezig","year":"2018","journal-title":"Metabolomics"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e84637","DOI":"10.1371\/journal.pone.0084637","article-title":"Follicular adenomas exhibit a unique metabolic profile. (1)H NMR studies of thyroid lesions","volume":"8","author":"Deja","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"14869","DOI":"10.1038\/srep14869","article-title":"Integrative metabonomics as potential method for diagnosis of thyroid malignancy","volume":"5","author":"Tian","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"30075","DOI":"10.1038\/srep30075","article-title":"Metabolomic analysis of percutaneous fine-needle aspiration specimens of thyroid nodules: Potential application for the preoperative diagnosis of thyroid cancer","volume":"6","author":"Ryoo","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Seo, J.W., Han, K., Lee, J., Kim, E.K., Moon, H.J., Yoon, J.H., Park, V.Y., Baek, H.M., and Kwak, J.Y. (2018). Application of metabolomics in prediction of lymph node metastasis in papillary thyroid carcinoma. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193883"},{"key":"ref_62","first-page":"3006","article-title":"Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study","volume":"41","author":"Li","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Metere, A., Graves, C.E., Chirico, M., Caramujo, M.J., Pisanu, M.E., and Iorio, E. (2020). Metabolomic reprogramming detected by (1)H-NMR spectroscopy in human thyroid cancer tissues. Biology, 9.","DOI":"10.3390\/biology9060112"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","article-title":"HMDB 4.0: The human metabolome database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Ravanbakhsh, S., Liu, P., Bjorndahl, T.C., Mandal, R., Grant, J.R., Wilson, M., Eisner, R., Sinelnikov, I., Hu, X., and Luchinat, C. (2015). Correction: Accurate, fully-automated NMR spectral profiling for metabolomics. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132873"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1021\/pr3010106","article-title":"1H HR-MAS NMR spectroscopy of tumor-induced local metabolic \u201cfield-effects\u201d enables colorectal cancer staging and prognostication","volume":"12","author":"Jimenez","year":"2013","journal-title":"J. Proteome Res."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Lutz, N.W., Sweedler, J.V., and Wevers, R.A. (2013). Methodologies for Metabolomics: Experimental Strategies and Techniques, Cambridge University Press.","DOI":"10.1017\/CBO9780511996634"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.talanta.2016.11.048","article-title":"Development of data-independent acquisition workflows for metabolomic analysis on a quadrupole-orbitrap platform","volume":"164","author":"Zhou","year":"2017","journal-title":"Talanta"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-1-4939-9706-0_20","article-title":"Untargeted metabolomics relative quantification by SWATH mass spectrometry applied to cerebrospinal fluid","volume":"2044","author":"Mendes","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12967-015-0408-1","article-title":"Perioperative dynamics and significance of amino acid profiles in patients with cancer","volume":"13","author":"Gu","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Ishikawa, S., Tateya, I., Hayasaka, T., Masaki, N., Takizawa, Y., Ohno, S., Kojima, T., Kitani, Y., Kitamura, M., and Hirano, S. (2012). Increased expression of phosphatidylcholine (16:0\/18:1) and (16:0\/18:2) in thyroid papillary cancer. PLoS ONE.","DOI":"10.1371\/journal.pone.0048873"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1007\/s00216-014-7846-0","article-title":"Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption\/ionization-Fourier transform ion cyclotron resonance mass spectrometry","volume":"406","author":"Guo","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s13361-016-1570-2","article-title":"Detection of metastatic breast and thyroid cancer in lymph nodes by desorption electrospray sionisation mass spectrometry imaging","volume":"28","author":"Zhang","year":"2017","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.aca.2019.05.068","article-title":"A graphical data processing pipeline for mass spectrometry imaging-based spatially resolved metabolomics on tumor heterogeneity","volume":"1077","author":"Huang","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5603\/EP.a2018.0003","article-title":"Discrimination of papillary thyroid cancer from non-cancerous thyroid tissue based on lipid profiling by mass spectrometry imaging","volume":"69","author":"Wojakowska","year":"2018","journal-title":"Endokrynol. Pol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3892\/ijmm.2015.2368","article-title":"GC-MS-based metabolomic analysis of human papillary thyroid carcinoma tissue","volume":"36","author":"Chen","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"11163","DOI":"10.1007\/s13277-016-4996-z","article-title":"Metabolomics of papillary thyroid carcinoma tissues: Potential biomarkers for diagnosis and promising targets for therapy","volume":"37","author":"Shang","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mce.2015.09.021","article-title":"Detection of metabolites discriminating subtypes of thyroid cancer: Molecular profiling of FFPE samples using the GC\/MS approach","volume":"417","author":"Wojakowska","year":"2015","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/cen.13437","article-title":"A distinct serum metabolic signature of distant metastatic papillary thyroid carcinoma","volume":"87","author":"Shen","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Caria, P., Tronci, L., Dettori, T., Murgia, F., Santoru, M.L., Griffin, J.L., Vanni, R., and Atzori, L. (2018). Metabolomic alterations in thyrospheres and adherent parental cells in papillary thyroid carcinoma cell lines: A pilot study. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19102948"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Tronci, L., Caria, P., Frau, D.V., Liggi, S., Piras, C., Murgia, F., Santoru, M.L., Pibiri, M., Deiana, M., and Griffin, J.L. (2019). Crosstalk between metabolic alterations and altered redox balance in PTC-derived cell lines. Metabolites, 9.","DOI":"10.3390\/metabo9020023"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-1-4939-9236-2_19","article-title":"El-MAVEN: A fast, robust, and user-friendly mass spectrometry data processing engine for metabolomics","volume":"1978","author":"Agrawal","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fcell.2020.00385","article-title":"Plasma Metabolic Profiling of Human Thyroid Nodules by Gas Chromatography-Mass Spectrometry (GC-MS)-Based Untargeted Metabolomics","volume":"8","author":"Abooshahab","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_84","first-page":"18013","article-title":"Analysis on the metabolite composition of serum samples from patients with papillary thyroid carcinoma using nuclear magnetic resonance","volume":"8","author":"Zhao","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_85","first-page":"1140","article-title":"Serum-based metabolic alterations in patients with papillary thyroid carcinoma unveiled by non-targeted 1H-NMR metabolomics approach","volume":"21","author":"Soroush","year":"2018","journal-title":"Iran J. Basic Med. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Zhou, Q., Zhang, L.Y., Xie, C., Zhang, M.L., Wang, Y.J., and Liu, G.H. (2019). Metabolomics as a potential method for predicting thyroid malignancy in children and adolescents. Pediatr. Surg. Int.","DOI":"10.1007\/s00383-019-04584-0"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0003-2670(03)00473-2","article-title":"Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from thyroid cancer patients","volume":"486","author":"La","year":"2003","journal-title":"Anal. Chim. Acta"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"9108","DOI":"10.1038\/s41598-017-09203-3","article-title":"Serum and urine (1)H NMR-based metabolomics in the diagnosis of selected thyroid diseases","volume":"7","author":"Wojtowicz","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1530\/ERC-19-0344","article-title":"Metabolite analysis-aided diagnosis of papillary thyroid cancer","volume":"26","author":"Chen","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/ijc.31925","article-title":"Serum-plasma matched metabolomics for comprehensive scharacterisation of benign thyroid nodule and papillary thyroid carcinoma","volume":"144","author":"Huang","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.aca.2019.02.021","article-title":"Plasma lipid profile comparison of five different cancers by nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry","volume":"1063","author":"Lee","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/ijc.32007","article-title":"Alterations in the gut microbiota and metabolite profiles of thyroid carcinoma patients","volume":"144","author":"Feng","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_93","first-page":"188","article-title":"Exhaled breath volatile biomarker analysis for thyroid cancer","volume":"166","author":"Guo","year":"2015","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Warburg, O. (1956). On the origin of cancer cells. Science, 123.","DOI":"10.1126\/science.123.3191.309"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_96","first-page":"119","article-title":"Reexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect","volume":"38","author":"Brooks","year":"2017","journal-title":"Carcinogenesis"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ijc.28949","article-title":"An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients","volume":"136","author":"An","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpba.2018.07.024","article-title":"Metabolic fingerprinting in breast cancer stages through (1)H NMR spectroscopy-based metabolomic analysis of plasma","volume":"160","author":"Suman","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1039\/C8AN01310A","article-title":"Diagnosis of pancreatic cancer via(1)H NMR metabolomics of human plasma","volume":"143","author":"Michalkova","year":"2018","journal-title":"Analyst"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJMra044389","article-title":"Tyrosine kinases as targets for cancer therapy","volume":"353","author":"Krause","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1089\/thy.2006.16.1163","article-title":"Biochemical markers in the follow-up of medullary thyroid cancer","volume":"16","author":"Groot","year":"2006","journal-title":"Thyroid"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1158\/0008-5472.CAN-15-2910","article-title":"Estrogen receptor alpha promotes breast cancer by reprogramming choline metabolism","volume":"76","author":"Jia","year":"2016","journal-title":"Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrc3162","article-title":"Choline metabolism in malignant transformation","volume":"11","author":"Glunde","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_104","first-page":"80","article-title":"Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells","volume":"59","author":"Aboagye","year":"1999","journal-title":"Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2147\/CMAR.S188661","article-title":"Oncometabolites as biomarkers in thyroid cancer: A systematic review","volume":"11","author":"Khatami","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/pro.3715","article-title":"Toward understanding the origin and evolution of cellular organisms","volume":"28","author":"Kanehisa","year":"2019","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Pang, Z., Chong, J., Li, S., and Xia, J. (2020). MetaboAnalystR 3.0: Toward an soptimised workflow for global metabolomics. Metabolites, 10.","DOI":"10.3390\/metabo10050186"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/acs.jproteome.5b00351","article-title":"Distinct metabolomic profiles of papillary thyroid carcinoma and benign thyroid adenoma","volume":"14","author":"Xu","year":"2015","journal-title":"J. Proteome Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1089\/thy.2016.0100","article-title":"Systematic review of trends in the incidence rates of thyroid cancer","volume":"26","author":"Wiltshire","year":"2016","journal-title":"Thyroid"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/15\/5272\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:51:34Z","timestamp":1760176294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/15\/5272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":110,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["ijms21155272"],"URL":"https:\/\/doi.org\/10.3390\/ijms21155272","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,24]]}}}